The Potential of Genetically Modified Soy to Manage HIV/AIDS in Africa

Solae, a US-based soy ingredient company, last weekcommitted to let the findings of this study
announced that it has commissioned a study topeer-reviewed and published in a respectable scientific
establish if soy products can be used to improve thejournal. The argument that junk science will be used
health of HIV/AIDS sufferers in South Africa.to develop this drink is, therefore, null and void.
In collaboration with the World Initiative for Soy inPredictably, opponents of genetically modified foods
Human Health (WISHH), and the University ofwill be out in droves to condemn Solae for trying "to
Stellenbosch in South Africa, Solae aims to make soyforce-feed Africans with genetically modified
protein-enhanced drinks for HIV/AIDS sufferers.Organisms (GMOs)."
This, inarguably, is an interesting venture, but theIf such were to happen, anti-biotech activists will be
million-dollar question is, "Will politics derail it?the most absurd lot in the world. They will be laying
I pose this question because the soy Solae will usebare their hypocrisy and ignorance about genetic
to develop these drinks will be genetically modified.engineering.
About 90 per cent of soy grown in the U.S. isAnti-biotech activists have been shouting from the
genetically modified.rooftops that pharmaceutical companies lower the
South Africa, on the other hand, is steadily becomingprices of anti-retroviral drugs, themselves products of
a hub of genetically modified crops. According to thegenetic engineering (GE).
latest report by the International Service for theIf genetic engineering is such an unsafe and
Acquisition of Agri-Biotech Applications (ISAAA), theunacceptable technology, why are anti-GE activists
bulk of soy currently being grown in South Africa isnot condemning biotech companies that manufacture
genetically engineered.anti-retroviral drugs?
Already, there are whispers out there that this is justThe envisaged soy protein-enhanced drink to manage
another conspiracy between the biotech industry andHIV/AIDS should be supported by all. It will be cheap
the academia to exploit the vulnerability of HIV/AIDSand readily available to many HIV/AIDS sufferers
sufferers in Africa to market genetically modifiedwho can't afford anti-retroviral drugs since Solae
products. This is gross distortion of facts.plans to make it available in supermarkets and other
Solae and other collaborating partners haveretail outlets.